These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 32111100)

  • 41. Using bioinspired thermally triggered liposomes for high-efficiency mixing and reagent delivery in microfluidic devices.
    Vreeland WN; Locascio LE
    Anal Chem; 2003 Dec; 75(24):6906-11. PubMed ID: 14670052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploring microfluidics and membrane extrusion for the formulation of temozolomide-loaded liposomes: investigating the effect of formulation and process variables.
    Waghule T; Saha RN; Singhvi G
    J Liposome Res; 2023 Jun; 33(2):170-182. PubMed ID: 36382856
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of montelukast sodium loaded niosomal carriers by film hydration technique.
    Kumar S; Awasthi R
    Antiinflamm Antiallergy Agents Med Chem; 2015; 14(1):63-78. PubMed ID: 25910042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive analysis of liposome formulation parameters and their influence on encapsulation, stability and drug release in glibenclamide liposomes.
    Maritim S; Boulas P; Lin Y
    Int J Pharm; 2021 Jan; 592():120051. PubMed ID: 33161039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Scalable microfluidic method for tunable liposomal production by a design of experiment approach.
    Buttitta G; Bonacorsi S; Barbarito C; Moliterno M; Pompei S; Saito G; Oddone I; Verdone G; Secci D; Raimondi S
    Int J Pharm; 2024 Sep; 662():124460. PubMed ID: 39004291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and characterization of minoxidil-loaded liposomal system for delivery to pilosebaceous units.
    Jain B; Singh B; Katare OP; Vyas SP
    J Liposome Res; 2010 Jun; 20(2):105-14. PubMed ID: 19698000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of risperidone liposomes for brain targeting through intranasal route.
    Narayan R; Singh M; Ranjan O; Nayak Y; Garg S; Shavi GV; Nayak UY
    Life Sci; 2016 Oct; 163():38-45. PubMed ID: 27593571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microfluidic Assembly of Liposomes with Tunable Size and Coloading Capabilities.
    Hoffman JR; Tasciotti E; Molinaro R
    Methods Mol Biol; 2018; 1792():205-214. PubMed ID: 29797262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liposomes produced by microfluidics and extrusion: A comparison for scale-up purposes.
    Shah VM; Nguyen DX; Patel P; Cote B; Al-Fatease A; Pham Y; Huynh MG; Woo Y; Alani AW
    Nanomedicine; 2019 Jun; 18():146-156. PubMed ID: 30876818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving the anti-inflammatory efficacy of dexamethasone in the treatment of rheumatoid arthritis with polymerized stealth liposomes as a delivery vehicle.
    Wang Q; He L; Fan D; Liang W; Fang J
    J Mater Chem B; 2020 Mar; 8(9):1841-1851. PubMed ID: 32016224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microfluidic remote loading for rapid single-step liposomal drug preparation.
    Hood RR; Vreeland WN; DeVoe DL
    Lab Chip; 2014 Sep; 14(17):3359-67. PubMed ID: 25003823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
    PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Study of Liposomal Formulations to Improve the Delivery of Aquated Cisplatin to a Multidrug Resistant Tumor.
    Zhao Y; May JP; Chen IW; Undzys E; Li SD
    Pharm Res; 2015 Oct; 32(10):3261-8. PubMed ID: 25964047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on the formulation and in vitro release of ophthalmic liposomes containing dexamethasone sodium phosphate.
    al-Muhammad J; Ozer AY; Hincal AA
    J Microencapsul; 1996; 13(2):123-30. PubMed ID: 8999118
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Encapsulation, stability and in-vitro release characteristics of liposomal formulations of colchicine.
    Kulkarni SB; Singh M; Betageri GV
    J Pharm Pharmacol; 1997 May; 49(5):491-5. PubMed ID: 9178182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Optimization of Formulation and Process of Paclitaxel PEGylated Liposomes by Box-Behnken Response Surface Methodology].
    Shi YJ; Zhang XF; Guo QT
    Zhong Yao Cai; 2015 Dec; 38(12):2606-10. PubMed ID: 27352544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultrasound-enhanced microfluidic synthesis of liposomes.
    Huang X; Caddell R; Yu B; Xu S; Theobald B; Lee LJ; Lee RJ
    Anticancer Res; 2010 Feb; 30(2):463-6. PubMed ID: 20332455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation, characterization and in vitro evaluation of sterically stabilized liposome containing a naphthalenediimide derivative as anticancer agent.
    Parise A; Milelli A; Tumiatti V; Minarini A; Neviani P; Zuccari G
    Drug Deliv; 2015; 22(5):590-7. PubMed ID: 24286206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microfluidic self-assembly of a combinatorial library of single- and dual-ligand liposomes for in vitro and in vivo tumor targeting.
    Ran R; Wang H; Liu Y; Hui Y; Sun Q; Seth A; Wibowo D; Chen D; Zhao CX
    Eur J Pharm Biopharm; 2018 Sep; 130():1-10. PubMed ID: 29908938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid optimization of liposome characteristics using a combined microfluidics and design-of-experiment approach.
    Sedighi M; Sieber S; Rahimi F; Shahbazi MA; Rezayan AH; Huwyler J; Witzigmann D
    Drug Deliv Transl Res; 2019 Feb; 9(1):404-413. PubMed ID: 30306459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.